Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone.
about
The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk FactorsInfectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.
P2860
Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@en
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@nl
type
label
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@en
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@nl
prefLabel
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@en
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@nl
P2093
P2860
P1476
Reduced risk of bacterial infe ...... ttent high-dose dexamethasone.
@en
P2093
Akihiro Manaka
Atsushi Isoda
Hirotaka Nakahashi
Momoko Mawatari
Morio Matsumoto
Morio Sawamura
P2860
P2888
P356
10.1007/S12185-010-0735-1
P577
2010-12-16T00:00:00Z